OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.310
-0.010 (-0.76%)
Aug 3, 2026, 4:00 PM EDT - Market closed
OPKO Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 439.45 | 606.9 | 713.14 | 863.5 | 1,004 | 1,775 |
Revenue Growth | -33.82% | -14.90% | -17.41% | -14.01% | -43.42% | 23.64% |
Gross Profit Gross Profit Growth | 91.27 | 205.9 | 218.51 | 318.13 | 288.22 | 581.52 |
Operating Income Operating Income Growth | -48.23 | -117.4 | -152.07 | -157.02 | -226.25 | 18.75 |
Net Income Net Income Growth | -72.83 | -225.7 | -53.21 | -188.76 | -328.02 | -29.51 |
Earnings Per Share EPS Growth | -0.09 | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Diagnostics Diagnostics Growth | 313.07 | 370.28 | 480.67 | 515.28 | 755.63 | 1,607 |
Pharmaceutical Pharmaceutical Growth | 274.83 | 236.6 | 232.48 | 348.22 | 248.57 | 167.61 |
Total Total Growth | 587.9 | 606.88 | 713.14 | 863.5 | 1,004 | 1,775 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 300.76 | 369.07 | 431.94 | 95.88 | 153.19 | 134.71 |
Total Debt Total Debt Growth | 392.26 | 389.44 | 495.7 | 308.75 | 286.55 | 247.35 |
Net Cash (Debt) Net Cash Growth | -91.5 | -20.36 | -63.76 | -212.87 | -133.36 | -112.64 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.12 | -0.03 | -0.09 | -0.28 | -0.19 | -0.17 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -197.03 | -183.49 | -28.2 | -95.19 | 38.34 | 39.48 |
Capital Expenditures CapEx Growth | -15.03 | -25.01 | -16.28 | -24.58 | -32.16 | -33.68 |
Free Cash Flow Free Cash Flow Growth | -212.06 | -208.5 | -44.47 | -119.77 | 6.18 | 5.79 |
Free Cash Flow Growth | - | - | - | - | 6.68% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 20.77% | 33.93% | 30.64% | 36.84% | 28.70% | 32.77% |
Operating Margin | -10.98% | -19.34% | -21.32% | -18.18% | -22.53% | 1.06% |
Pretax Margin | -17.72% | -39.78% | 18.42% | -24.51% | -55.45% | -0.79% |
Profit Margin | -16.60% | -37.19% | -7.46% | -21.87% | -32.70% | -1.70% |
FCF Margin | 0.00% | 0.00% | -29.24% | -5.15% | -11.93% | 0.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 88.08 | 88.08 | 88.08 | 88.08 | 103.61 |
P/FCF Ratio | - | - | - | - | - | 530.28 |
PS Ratio | 1.66 | 1.58 | 1.38 | 1.35 | 0.96 | 1.85 |